Finance

Lists
T1CH34:BVMF
Bio Techne Corporation Bdr
R$13.38
+0.07%
(+0.0099) 1D
Nov 10, 4:56:50 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for T1CH34...
Mkt. cap
11.43B
Avg. vol.
26.00
Volume
0.00
52-wk high
R$13.37
52-wk low
R$7.33
Shares outstanding
157.09M
No. of employees
3K
Mkt. cap
11.43B
Avg. vol.
26.00
Volume
0.00
52-wk high
R$13.37
52-wk low
R$7.33
Shares outstanding
157.09M
No. of employees
3K
News stories
From web sources and news partners
Profile
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. Wikipedia
About Bio Techne Corporation Bdr
CEOKim Kelderman
Employees3K
Founded1976
HeadquartersMinneapolis, Minnesota, United States
SectorHealth Care
Industry-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
295.88M
311.42M
321.19M
299.71M
Cost of goods sold
102.69M
101.98M
109.14M
101.68M
Cost of revenue
102.69M
101.98M
109.14M
101.68M
Research and development expenses
23.12M
23.46M
23.94M
26.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
111.87M
107.54M
98.59M
131.42M
Operating expense
134.99M
130.99M
122.53M
157.76M
Total operating expenses
237.68M
232.97M
231.67M
259.44M
Operating income
58.20M
78.45M
89.52M
40.27M
Other non operating income
-2.51M
-2.11M
1.89M
-3.47M
EBT including unusual items
50.78M
71.22M
70.68M
34.69M
EBT excluding unusual items
54.52M
74.18M
91.79M
38.36M
Income tax expense
12.78M
20.18M
16.06M
6.40M
Effective tax rate
25.16%
28.33%
22.72%
18.45%
Other operating expenses
-
-
-
-
Net income
38.01M
51.05M
54.62M
28.29M
Net profit margin
12.85%
16.39%
17.01%
9.44%
Earnings per share
0.46
0.53
0.52
0.44
Interest and investment income
897.00K
981.00K
1.37M
1.96M
Interest expense
-2.17M
-2.40M
-2.12M
-2.17M
Net interest expenses
-1.27M
-1.42M
-750.00K
-214.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
82.91M
102.62M
113.66M
63.99M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps